These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23026230)

  • 1. Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence?
    Takahashi M; Maruyama H; Shimada T; Kamezaki H; Okabe S; Kanai F; Yoshikawa M; Yokosuka O
    Ultrasound Med Biol; 2012 Nov; 38(11):1902-10. PubMed ID: 23026230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation.
    Maruyama H; Takahashi M; Shimada T; Sekimoto T; Kamesaki H; Kanai F; Yokosuka O
    AJR Am J Roentgenol; 2013 Mar; 200(3):570-7. PubMed ID: 23436846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
    J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
    Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
    Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
    Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
    AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
    Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
    J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
    Wang Y; Liao J; Qi W; Xie L; Li Y
    Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
    Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
    World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
    Wiggermann P; Brünn K; Rennert J; Loss M; Wobser H; Schreyer AG; Stroszczynski C; Jung EM
    Ultraschall Med; 2013 Dec; 34(6):590-4. PubMed ID: 24132649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.
    Barat M; Fohlen A; Cassinotto C; Jannot AS; Dautry R; Pelage JP; Boudiaf M; Pocard M; Eveno C; Taouli B; Soyer P; Dohan A
    J Magn Reson Imaging; 2017 Jun; 45(6):1648-1658. PubMed ID: 27766709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma.
    Dohmen T; Kataoka E; Yamada I; Miura K; Ohshima S; Shibuya T; Segawa D; Sato W; Anezaki Y; Ishii H; Kamada K; Goto T; Ohnishi H
    Intern Med; 2012; 51(1):1-7. PubMed ID: 22214616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast harmonic sonographically guided radio frequency ablation for spontaneous ruptured hepatocellular carcinoma.
    Tamai H; Oka M; Maeda H; Shingaki N; Kanno T; Enomoto S; Shiraki T; Iguchi M; Nakazawa K; Arii K; Yanaoka K; Shimizu Y; Nakata H; Fujishiro M; Yahagi N; Shiina S; Ichinose M
    J Ultrasound Med; 2005 Jul; 24(7):1021-6. PubMed ID: 15972719
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy.
    Chen MH; Wu W; Yang W; Dai Y; Gao W; Yin SS; Yan K
    J Ultrasound Med; 2007 Aug; 26(8):1055-63. PubMed ID: 17646367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience.
    Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski TT; Bernatik T; Hahn EG; Strobel D
    Ultraschall Med; 2007 Dec; 28(6):604-11. PubMed ID: 18074314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence.
    Kei SK; Rhim H; Choi D; Lee WJ; Lim HK; Kim YS
    AJR Am J Roentgenol; 2008 Jun; 190(6):1544-51. PubMed ID: 18492905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.